B.K. is currently in private practice as a gastroenterologist in Schwetzingen, Germany.
Article first published online: 26 JAN 2006
Copyright © 2006 American Association for the Study of Liver Diseases
Volume 43, Issue 2, pages 250–256, February 2006
How to Cite
Wiegand, J., Buggisch, P., Boecher, W., Zeuzem, S., Gelbmann, C. M., Berg, T., Kauffmann, W., Kallinowski, B., Cornberg, M., Jaeckel, E., Wedemeyer, H. and Manns, M. P. (2006), Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: The HEP-NET acute-HCV-II study. Hepatology, 43: 250–256. doi: 10.1002/hep.21043
See Editorial on Page 221
Potential conflict of interest: Dr. Zeuzem is a consultant for and has received unrestricted grants from Roche and Schering. Dr. Wiegand has received travel grants from Schering. Drs. Jaeckel and Comberg have received travel grants from Essex Pharma. Dr. Wedemeyer has received research and travel grants from Essex Pharma. Dr. Manns is a consultant for and has received research and travel grants from Schering. Dr. Buggisch is a consultant for, has received research and travel grants from, and has conducted clinical trials for Roche. He has also been a consultant and conducted clinical trials for Schering-Plough.
- Issue published online: 26 JAN 2006
- Article first published online: 26 JAN 2006
- Manuscript Accepted: 23 NOV 2005
- Manuscript Received: 3 AUG 2005
- Study House of the German Competence Network for Viral Hepatitis
- BMBF (German Federal Ministry for Education and Research)
- Essex Pharma GmbH
- 10Acute hepatitis C infection: can immunology teach us the right way to treat? Curr Hepat Rep 2004; 3: 148–156., , , .